Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.08 USD | -0.16% | -3.69% | -15.04% |
Mar. 14 | JMP Securities Raises Price Target on Mirum Pharmaceuticals to $72 From $69, Maintains Market Outperform Rating | MT |
Mar. 14 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
Financials (USD)
Sales 2024 * | 317M | Sales 2025 * | 420M | Capitalization | 1.18B |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | 33M | EV / Sales 2024 * | 2.98 x |
Net cash position 2024 * | 237M | Net cash position 2025 * | 315M | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
-24.7
x | P/E ratio 2025 * |
42.6
x | Employees | 264 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.86% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | +1.15% | ||
1 week | -2.30% | ||
Current month | -11.39% | ||
1 month | -11.94% | ||
3 months | -15.09% | ||
6 months | -19.39% | ||
Current year | -13.82% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 25.08 | -0.16% | 424 360 |
24-03-27 | 25.12 | +0.80% | 401,405 |
24-03-26 | 24.92 | -4.67% | 462,256 |
24-03-25 | 26.14 | +0.04% | 471,526 |
24-03-22 | 26.13 | +0.35% | 485,046 |
Delayed Quote Nasdaq, March 28, 2024 at 11:37 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.82% | 1.18B | |
+9.04% | 45.97B | |
+52.39% | 43.93B | |
+7.32% | 42.34B | |
-8.78% | 28.27B | |
+17.94% | 27.18B | |
-20.86% | 19.44B | |
+14.62% | 13.83B | |
+32.02% | 12.4B | |
+9.82% | 11.45B |